Nano Science and Technology Institute

Nanosphere, Inc. Receives FDA Clearance for Nano-Enabled Molecular Diganostic Platform and Approval for Warafin Sensitivity Testing

Nanosphere, Inc., announced this month that it received FDA clearance for its VerigeneĀ® System, a random access, molecular diagnostics workstation that uses gold nanoparticle probe technology for nucleic acid and protein diagnostics. This is the first nano-enabled medical diagnostics test cleared by the FDA. According to the diagnostics company, ā€œ easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform.ā€ Nanosphere, Inc. also received FDA approval for the first genetic test of the VerigeneĀ® System for warafin sensitivity.

↑ Back to Nano World Breaking News™

↑ Back to Nano World News™

Nano World News™ Issue Archive:

RSS feed RSS feed

© 2014 Nano Science and Technology Institute. All Rights Reserved.
Terms of Use | Privacy Policy | Contact Us | Site Map